Media-OutReach Newswire Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized Phase 2b/3 clinical trial
Media-OutReach Newswire Achiko Limited: Achiko and TrustScan partner to restart businesses safely and sooner in a world learning to live with Covid-19
Media-OutReach Newswire Allianz Risk Barometer 2020: Business interruption and natural catastrophes remain top risks amongst China companies
Media-OutReach Newswire Allianz Risk Barometer 2020: Cyber top peril for Asia-Pacific companies for the first time